Clinical Features and Outcomes of Repeated Endoscopic Therapy for Esophagogastric Variceal Hemorrhage in Cirrhotic Patients: Ten-Year Real-World Analysis

<div>The cumulative survival rates in viral and nonviral hepatitis. (a) The 3-year cumulative survival rates in viral and nonviral hepatitis. (b) The 5-year cumulative survival rates in viral and nonviral hepatitis. (c) The cumulative survival rate for the first 15 months after endotherapy in viral and nonviral hepatitis. (d) The cumulative survival rate from 15 to 60 months after endotherapy in viral and nonviral hepatitis.</div>

Gastroenterology Research and Practice

fig2

Figure 2

Figure 2: Clinical Features and Outcomes of Repeated Endoscopic Therapy for Esophagogastric Variceal Hemorrhage in Cirrhotic Patients: Ten-Year Real-World Analysis 

Figure 2 | Clinical Features and Outcomes of Repeated Endoscopic Therapy for Esophagogastric Variceal Hemorrhage in Cirrhotic Patients: Ten-Year Real-World Analysis 